Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma
Sandro Stöckli, Hans Steinert, Madeleine Pfaltz & Stephan Schmid
abstract
|
BACKGROUND: The aim of our study was to assess the value of positron
emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the
staging of clinically nodal negative necks in oral and oropharyngeal
squamous cell carcinoma (SCC) using sentinel lymph node (SLN) biopsy
and elective neck dissection (END) as "gold standard" for
comparison. METHODS: Twelve patients (10 men, 2 women) with oral or
oropharyngeal squamous cell carcinoma and no evidence of lymph node
metastasis in the physical and radiologic examinations were
eligible. At least 24 hours before surgery PET with FDG were
performed. The SLN was localized by preoperative lymphoscintigraphy
with 99m-Tc-Nanocoll and intraoperative use of a hand-held
gamma-probe and selectively excised. All patients then underwent
END. RESULTS: SLN and END revealed occult metastasis in 5 of 12
cases. SLN biopsy was accurately feasible in all 12 patients and
diagnosed all 5 cases of occult metastasis (sensitivity and
specificity of 100%). PET suggested two patients having occult
metastasis, of which one turned out to be false positive
(sensitivity 25%, specificity 88%). The mean size of the
micrometastasis was 1.4 mm (range, 1.2-1.5 mm). CONCLUSIONS: PET
with FDG turned out to have a poor sensitivity and specificity in
revealing occult metastasis and has no role for the evaluation of
otherwise clinically N0 necks. The failure to detect micrometastasis
by PET is due to the technical limitations of resolution (4-5 mm).
SLN biopsy, with END in cases of positive SLN, provides a highly
accurate staging of N0 necks in oral and oropharyngeal carcinoma.
Patients with negative SLN could be spared the risks and the
morbidity of END.
|
|
|
citation
|
Stöckli S, Steinert H, Pfaltz M, Schmid S. Is there a role for
positron emission tomography with 18F-fluorodeoxyglucose in the
initial staging of nodal negative oral and oropharyngeal squamous
cell carcinoma. Head & neck 2002; 24:345-9.
|
|
|
type
|
journal paper/review (English)
|
date of publishing
|
4-2002
|
journal title
|
Head & neck (24/4)
|
ISSN print
|
1043-3074
|
pages
|
345-9
|
PubMed
|
11933176
|
additional links & downloads